Elixinol Wellness Ltd (AU:EXL) — Market Cap & Net Worth
Market Cap & Net Worth: Elixinol Wellness Ltd (EXL)
Elixinol Wellness Ltd (AU:EXL) has a market capitalization of $2.05 Million (AU$2.90 Million) as of September 21, 2026. Listed on the AU stock exchange, this Australia-based company holds position #30074 globally and #1752 in its home market, demonstrating a -12.50% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Elixinol Wellness Ltd's stock price AU$0.01 by its total outstanding shares 413987731 (413.99 Million). Also see total assets of Elixinol Wellness Ltd for a full breakdown of the balance sheet.
Elixinol Wellness Ltd Market Cap History: 2018 to 2026
Elixinol Wellness Ltd's market capitalization history from 2018 to 2026. Data shows change from $632.04 Million to $2.05 Million (-44.91% CAGR). Also see Elixinol Wellness Ltd (EXL) cash flow conversion for how efficiently the company converts equity into cash flow.
Elixinol Wellness Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Elixinol Wellness Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check EXL stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.17x
Elixinol Wellness Ltd's market cap is 0.17 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $632.04 Million | $37.13 Million | -$860.00K | 17.02x | N/A |
| 2019 | $142.86 Million | $30.71 Million | -$80.62 Million | 4.65x | N/A |
| 2020 | $51.26 Million | $15.01 Million | -$104.51 Million | 3.42x | N/A |
| 2021 | $21.09 Million | $9.34 Million | -$17.02 Million | 2.26x | N/A |
| 2022 | $6.15 Million | $7.05 Million | -$10.57 Million | 0.87x | N/A |
| 2023 | $3.52 Million | $8.27 Million | -$7.51 Million | 0.43x | N/A |
| 2024 | $11.13 Million | $14.96 Million | -$1.72 Million | 0.74x | N/A |
| 2025 | $2.64 Million | $15.50 Million | -$5.50 Million | 0.17x | N/A |
Competitor Companies of EXL by Market Capitalization
Companies near Elixinol Wellness Ltd in the global market cap rankings as of September 21, 2026. Review how tangible is Elixinol Wellness Ltd's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Elixinol Wellness Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #612 globally with a market cap of $44.92 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #612 | GALDERMA GROUP AG | NYSE:GALDY | $44.92 Billion | $38.53 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.90 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.99 Billion | CN¥43.91 |
Elixinol Wellness Ltd Historical Marketcap From 2018 to 2026
Between 2018 and today, Elixinol Wellness Ltd's market cap moved from $632.04 Million to $ 2.05 Million, with a yearly change of -44.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$2.05 Million | -22.22% |
| 2025 | AU$2.64 Million | -76.32% |
| 2024 | AU$11.13 Million | +216.67% |
| 2023 | AU$3.52 Million | -42.86% |
| 2022 | AU$6.15 Million | -70.83% |
| 2021 | AU$21.09 Million | -58.86% |
| 2020 | AU$51.26 Million | -64.12% |
| 2019 | AU$142.86 Million | -77.40% |
| 2018 | AU$632.04 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 20th, 2026 the market cap of Elixinol Wellness Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.05 Million USD |
| MoneyControl | $2.05 Million USD |
| MarketWatch | $2.05 Million USD |
| marketcap.company | $2.05 Million USD |
| Reuters | $2.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Elixinol Wellness Ltd
Elixinol Wellness Limited, a holding company, produces and sells human nutrition, human wellness, pet wellness, and superfood ingredients in Australia, the Americas, and internationally. The company offers its products under Hemp Foods Australia, Mt Elephant, The Healthy Chef, Soul Foods, Ananda Equine, and Field Day brands. It distributes its products through grocery, wholesale, and e-commerce c… Read more